https://www.selleckchem.com/pr....oducts/Bortezomib.ht
· The WHO defines benign, intermediate, and malignant chondrogenic bone tumors. · Frequent benign tumors osteochondroma and enchondroma; Frequent malignant tumor conventional chondrosarcoma. · Differentiation between enchondroma versus low-grade chondrosarcoma is challenging for radiologists and pathologists. · Pain, deep scalloping, cortical destruction, bone expansion, soft tissue component favor chondrosarcoma. · Potential malignant transformation of osteochondroma progression after skeletal maturity, cartilage cap thickness (&g
إعجاب
علق
شارك
